Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 2093101 · RNA

Atrium Therapeutics, Inc.

Filing with the SEC SEC-reporting company San Diego, CA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Change in controlOn Feb 27, 2026 the company reported a change in control (Item 5.01).
  • Stockholders’ deficitAt the end of 2025 total liabilities exceeded total assets: stockholders’ equity was −$62.7M (XBRL data filed with the SEC).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Total assets$8.4M—
Total liabilities$71.1M—
Stockholders’ equity−$62.7M−$61.1M
Cash and equivalents$0$0

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Atrium Therapeutics, Inc.
CIK
0002093101
Tickers
RNA
Kind of filer
SEC-reporting company
Emerging growth company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
San Diego, California
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
None in our data
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 12, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 13, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 13, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 5.01, 5.02, 9.01 · filed Feb 27, 2026 · filing
  • Change in control
    Form 8-K · items 1.01, 5.01, 5.02, 9.01 · filed Feb 27, 2026 · filing
  • Form 10 registration: Registration of a class of securities (Form 10)
    Form 10-12B · filed Dec 10, 2025 · filing